Several studies show a deregulation of the expression of CB1 in Alzheimer’s disease; however, while in animal models it seems clear that there is a decrease in this receptor [35,47,48], in humans, there is more controversy, since its expression depends on the stage of the disease [22]. This evidence concerns the gene CNR1 and early-onset autosomal dominant Alzheimer disease.